Catherine Huntington
Associate Director AstraZeneca
Catherine is an Associate Director leading a team within Biologics Engineering (BE) at AstraZeneca, based in Cambridge, UK, working on the development of innovative antibody-based modalities for the treatment of respiratory and immunology indications. She has over 20 years’ experience in the Biotechnology Industry. Broad knowledge of all aspects of the drug discovery process for Biologics across multiple therapeutic areas and contributing to various drug programs in clinical development both for systemic delivery and inhalation space. She is currently responsible for leading the developability guidance for inhaled biologics and overseeing early-stage research projects within BE for multispecifics in the Respiratory and Immunology therapy area.
Seminars
- Where do bispecifics truly outperform monoclonals or RNA therapies in chronic, non-oncology diseases?
- How should bispecifics be designed to unlock new biology beyond immune effector functions?
- What needs to change in biomarkers, dosing, and trial design to prove value outside oncology?
